Analysts expect Select Medical Holdings Corporation (NYSE:SEM) to announce $1.09 billion in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Select Medical Holdings Corporation’s earnings. The highest sales estimate is $1.11 billion and the lowest is $1.08 billion. Select Medical Holdings Corporation reported sales of $1.05 billion during the same quarter last year, which indicates a positive year over year growth rate of 3.8%. The company is scheduled to report its next quarterly earnings report after the market closes on Thursday, November 2nd.

According to Zacks, analysts expect that Select Medical Holdings Corporation will report full-year sales of $1.09 billion for the current fiscal year, with estimates ranging from $4.40 billion to $4.44 billion. For the next financial year, analysts anticipate that the firm will report sales of $5.15 billion per share. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that cover Select Medical Holdings Corporation.

Select Medical Holdings Corporation (NYSE:SEM) last posted its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.32 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.25 by $0.07. Select Medical Holdings Corporation had a return on equity of 9.61% and a net margin of 1.95%. The company had revenue of $1.12 billion for the quarter, compared to analysts’ expectations of $1.13 billion. During the same period last year, the firm earned $0.23 earnings per share. Select Medical Holdings Corporation’s quarterly revenue was up 2.1% on a year-over-year basis.

A number of equities research analysts have recently issued reports on SEM shares. Zacks Investment Research upgraded shares of Select Medical Holdings Corporation from a “sell” rating to a “hold” rating in a research note on Thursday, July 6th. BidaskClub lowered shares of Select Medical Holdings Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Robert W. Baird upgraded shares of Select Medical Holdings Corporation from a “neutral” rating to an “outperform” rating and upped their target price for the company from $15.00 to $21.00 in a research note on Monday, August 7th. Benchmark Co. upped their target price on shares of Select Medical Holdings Corporation from $17.00 to $20.00 and gave the company a “buy” rating in a research note on Monday, August 7th. Finally, Deutsche Bank AG upped their target price on shares of Select Medical Holdings Corporation from $20.00 to $22.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. Select Medical Holdings Corporation currently has an average rating of “Hold” and a consensus price target of $18.14.

COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/11/02/1-09-billion-in-sales-expected-for-select-medical-holdings-corporation-sem-this-quarter.html.

In related news, insider Michael E. Tarvin sold 18,500 shares of the stock in a transaction dated Monday, October 30th. The shares were sold at an average price of $18.97, for a total transaction of $350,945.00. Following the sale, the insider now owns 340,044 shares in the company, valued at $6,450,634.68. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider David S. Chernow sold 133,025 shares of the stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $17.85, for a total transaction of $2,374,496.25. Following the sale, the insider now owns 729,815 shares in the company, valued at approximately $13,027,197.75. The disclosure for this sale can be found here. 19.93% of the stock is owned by corporate insiders.

Large investors have recently made changes to their positions in the business. PNC Financial Services Group Inc. increased its stake in shares of Select Medical Holdings Corporation by 0.8% in the first quarter. PNC Financial Services Group Inc. now owns 8,313 shares of the health services provider’s stock valued at $111,000 after purchasing an additional 70 shares during the period. Pacad Investment Ltd. increased its stake in shares of Select Medical Holdings Corporation by 58.7% in the second quarter. Pacad Investment Ltd. now owns 7,300 shares of the health services provider’s stock valued at $112,000 after purchasing an additional 2,700 shares during the period. Envestnet Asset Management Inc. increased its stake in shares of Select Medical Holdings Corporation by 1.2% in the first quarter. Envestnet Asset Management Inc. now owns 9,317 shares of the health services provider’s stock valued at $125,000 after purchasing an additional 107 shares during the period. Riverhead Capital Management LLC increased its stake in shares of Select Medical Holdings Corporation by 78.0% in the second quarter. Riverhead Capital Management LLC now owns 8,722 shares of the health services provider’s stock valued at $134,000 after purchasing an additional 3,822 shares during the period. Finally, Flinton Capital Management LLC increased its stake in shares of Select Medical Holdings Corporation by 75.8% in the second quarter. Flinton Capital Management LLC now owns 9,744 shares of the health services provider’s stock valued at $150,000 after purchasing an additional 4,200 shares during the period. Institutional investors own 78.94% of the company’s stock.

About Select Medical Holdings Corporation

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Get a free copy of the Zacks research report on Select Medical Holdings Corporation (SEM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Select Medical Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.